Skip to content

Drug interactions

Crizotinib + Eliglustat

Severity: Major

Crizotinib and Eliglustat: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Crizotinib may increase eliglustat concentrations by inhibiting CYP3A4, and both agents can prolong the QT interval. Elevated eliglustat levels raise the risk of cardiac conduction abnormalities and arrhythmia.

What this interaction means in plain words

Crizotinib and Eliglustat can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Crizotinib belongs to Oncology; Eliglustat belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Crizotinib inhibits CYP3A4 (eliglustat metabolism) and both drugs have additive QTc-prolonging effects.

What to do

Avoid the combination in CYP2D6 poor or intermediate metabolizers; in extensive metabolizers reduce eliglustat dose per labeling and monitor ECG.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Eliglustat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Crizotinib with Eliglustat?

MediHelp rates the interaction as major. Crizotinib and Eliglustat can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Crizotinib may increase eliglustat concentrations by inhibiting CYP3A4, and both agents can prolong the QT interval. Elevated eliglustat levels raise the risk of cardiac conduction abnormalities and arrhythmia.

How serious is the interaction between Crizotinib and Eliglustat?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination in CYP2D6 poor or intermediate metabolizers; in extensive metabolizers reduce eliglustat dose per labeling and monitor ECG.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in